Posted on January 03, 2018
2017 was an exciting time of growth for Medtechy and we would like to thank you all for reading, visiting and sharing.
Over the course of 2017, the visitors to our anonymous message boards increased as the word continued to get out about Medtechy. We have a mixed viewership of employees in the medical sales industry and investors interested in biotech and medical device.
Additionally, our blog was up for its first full year and we tested out an eclectic mix of stories covering everything from sales tips to observational pieces of medical technology, including robotic surgery, wearables and social media's impact on the biotech industry.
We don't have an agenda. The only thing we hope is that you enjoy, read and share our site with your colleagues. Have a great start to 2018 and we look forward to sharing some exciting additions to Medtechy in the coming months.
Top 10 Medtechy Articles From 2017
Late last week, The Lancet, published an eye opening study concluding that stents fail to ease chest pain.
Let's just get this out of the way: Mazor wants to grow and Medtronic needs to infuse growth into their Spine business.
Senhance is the first new entrant into the abdominal surgical robotics market since the year 2000.
There's been significant rumors of loosening with Depuy's Attune Knee System over the last two years and they are only intensifying.
Want to know how patients really feel about a medication they are taking? Check out social media.
Wearable technology such as the Apple Watch have shown promise with their fitness capabilities, and the future has always appeared bright in relation to their value to healthcare, but technology hasn't caught up to the potential. Until now.
Medtronic has done a great job of keeping a tight lid on their robotic surgery program. What is it called?
Stryker (Howmedica Osteonics Corp) takes their non-compete agreements seriously.
Pre-call plans are one of the most effective tools a sales rep can use in preparing for a sales call. However, in our experience, sales reps bypass using them unless they happen to be on a field ride with their manager.
A number of companies, including TransEnterix, are set to enter the robotic surgery market in the coming years. The market is projected to reach over $20 billion by 2024, but there's this little company named Intuitive Surgical waiting with history and a massive sales and marketing organization on its side.